GLP-1 Medications and Gallstones: What Patients Should Know
Dr. Michael Baptista, a Jacksonville bariatric and general surgeon, explains why GLP-1 weight loss medications raise the risk of gallstones, the symptoms to watch for, and when gallbladder surgery becomes the right answer.


The Short Answer
Yes, GLP-1 medications are associated with a higher risk of gallstones and gallbladder problems, and the risk is highest in exactly the people most likely to be taking them: patients using them for weight loss, at the higher doses, for longer than a few months. Most patients will never have a problem. For the ones who do, the symptoms are recognizable, the evaluation is simple, and the treatment is one of the most common operations I perform. If you are on a GLP-1 medication, from any prescriber, and you are having nausea and/or pain under your right ribs after eating, this article is for you.
Why GLP-1 Medications Raise the Risk
Two things are happening at once.
The first is weight loss itself. Losing weight quickly, by any method, raises the risk of gallstones. As the body burns fat, the liver releases more cholesterol into bile, and the gallbladder can become supersaturated. Bariatric surgeons have known this for decades, because our patients lose weight faster than almost anyone. It is one of the reasons we follow our surgical patients so closely in the first year.
The second is the medication. GLP-1 medications slow the digestive system, including the gallbladder. A gallbladder that empties less often lets bile sit longer, and stagnant bile forms stones. A 2022 analysis in JAMA Internal Medicine pooled 76 randomized trials covering more than 100,000 patients and found that GLP-1 use was associated with a 37 percent higher relative risk of gallbladder or biliary disease. The risk was greater with higher doses, longer treatment, and when the medication was prescribed for weight loss rather than diabetes.
Put plainly: rapid weight loss raises gallstone risk, GLP-1 medications slow the gallbladder, and patients on GLP-1s for weight loss get both at once.
Symptoms to Watch For
Most gallstones cause no symptoms and need no treatment. The ones that matter announce themselves:
- Pain in the upper right abdomen or the center of the upper abdomen, often starting 30 to 60 minutes after a meal, especially a fatty one
- Pain that radiates to the right shoulder blade or the back
- Nausea or vomiting with the pain
- Episodes that last from 30 minutes to several hours and then fade
Some symptoms mean the problem has become urgent. Fever and chills, pain that will not let up after several hours, yellowing of the skin or eyes, dark urine, or pale stools can signal an infected gallbladder, a stone blocking the bile duct, or pancreatitis. Those are reasons to go to the emergency room, not to wait for an appointment.
One point that trips up patients on GLP-1 medications: nausea, bloating, and upper abdominal discomfort are also ordinary side effects of the medication. Patients and sometimes their prescribers assume gallbladder pain is "just the GLP-1" for weeks or months. Pain that is tied to meals, sits under the right ribs, or comes in distinct attacks is not a medication side effect to push through. It needs an evaluation.
How We Evaluate It
The workup is quick. A conversation about your symptoms and your medication history, an exam, blood work to check the liver and pancreas, and an ultrasound of the abdomen, which finds gallstones reliably and takes about 20 minutes. In some cases a CT scan or a specialized scan of gallbladder function adds information.
I want to know everything you are taking and for how long. Many of the patients I see with gallbladder symptoms started their GLP-1 medication through an online service, a med spa, or a primary care office, and no one on that side is watching for this. That is not a criticism of anyone. It is the reason a surgeon belongs in the conversation once symptoms start.
When Surgery Is the Answer
Gallstones that cause symptoms do not go away on their own, and the attacks tend to come back, often worse. The treatment is removal of the gallbladder, a procedure called cholecystectomy. I perform it laparoscopically through one or two small incisions. Most patients go home the same day and are back to normal activity within a week or two. You do not need your gallbladder; the liver continues to produce bile, which flows directly into the intestine.
Two questions come up constantly with GLP-1 patients, so let me answer them here.
Do I have to stop my GLP-1 medication for surgery? Not necessarily, and not on your own. Because these medications slow stomach emptying, there is a concern about food remaining in the stomach during anesthesia. Normally, anesthesia will require stopping the GLP-1 dose a week before surgery. A liquid diet the day before and a few other precautions are sometimes recommended. Tell your surgeon and your anesthesiologist that you take a GLP-1 medication, and let them decide. Do not stop it on your own, and do not hide it.
Can I keep taking my GLP-1 after my gallbladder is removed? In most cases, yes. Gallbladder removal takes away the organ that was forming the stones. Once you have recovered, continuing the medication is usually fine, and that decision is made with the prescriber.
If You Are on a GLP-1 and Not Sure What You Are Feeling
You do not need to have been my patient, and you do not need to have had weight loss surgery, to be seen for this. If you are taking a GLP-1 medication and have pain after meals, right-sided abdominal pain, or symptoms your prescriber has not been able to explain, an evaluation with a surgeon who treats both the gallbladder and weight is the fastest way to an answer.
Call our office at (904) 724-2263 or contact us online. You can read more about gallbladder surgery, and if you are weighing your weight loss options more broadly, about our Medical Weight Loss Program.
Sources
- He L, Wang J, Ping F, et al. Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Internal Medicine. 2022;182(5):513-519.
- Multisociety Clinical Practice Guidance for the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in the Perioperative Period. American Society of Anesthesiologists, American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, International Society of Perioperative Care of Patients with Obesity, and Society of American Gastrointestinal and Endoscopic Surgeons. 2024.
- Sodhi M, et al. Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss. JAMA. 2023;330(18):1795-1797.
This article is for general education and is not a substitute for medical advice. Please see our medical disclaimer.
